Precision Microbiome Engineering

Targeted modification of gut microbiota to restore youthful metabolic and immune profiles.

The gut microbiome changes with age, contributing to inflammation, immune dysfunction, and metabolic disease. This approach uses defined consortia of beneficial bacteria, phage therapy to remove pathobionts, and prebiotics/postbiotics tailored to individual microbiome profiles. Goals include enhanced longevity metabolite production (butyrate, urolithin A) and reduced systemic inflammation.

TRL
6/9Demonstrated
Impact
4/5
Investment
3/5
Category
Applications